Point72 Asset Management
SAGE

Point72 Asset Management’s Sage Therapeutics SAGE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-79
Closed -$627 1770
2025
Q1
$627 Buy
+79
New +$627 ﹤0.01% 1216
2024
Q3
Sell
-6,200
Closed -$67.3K 1639
2024
Q2
$67.3K Sell
6,200
-635,011
-99% -$6.9M ﹤0.01% 1102
2024
Q1
$12M Buy
+641,211
New +$12M 0.03% 548
2023
Q4
Sell
-110,000
Closed -$2.26M 1983
2023
Q3
$2.26M Buy
+110,000
New +$2.26M 0.01% 817
2022
Q4
Sell
-801,600
Closed -$31.4M 1373
2022
Q3
$31.4M Sell
801,600
-457,700
-36% -$17.9M 0.13% 205
2022
Q2
$40.7M Buy
1,259,300
+818,300
+186% +$26.4M 0.17% 156
2022
Q1
$14.6M Buy
441,000
+104,100
+31% +$3.45M 0.06% 374
2021
Q4
$14.3M Sell
336,900
-420,500
-56% -$17.9M 0.06% 395
2021
Q3
$33.6M Buy
757,400
+529,200
+232% +$23.4M 0.15% 171
2021
Q2
$13M Sell
228,200
-105,500
-32% -$5.99M 0.06% 363
2021
Q1
$25M Buy
+333,700
New +$25M 0.12% 212
2020
Q4
Sell
-302,214
Closed -$18.5M 1043
2020
Q3
$18.5M Buy
302,214
+179,080
+145% +$10.9M 0.09% 277
2020
Q2
$5.12M Buy
+123,134
New +$5.12M 0.03% 452
2019
Q1
Sell
-256,459
Closed -$24.6M 1086
2018
Q4
$24.6M Buy
256,459
+81,459
+47% +$7.8M 0.12% 185
2018
Q3
$24.7M Buy
175,000
+35,000
+25% +$4.94M 0.1% 189
2018
Q2
$21.9M Buy
140,000
+37,400
+36% +$5.85M 0.09% 218
2018
Q1
$16.5M Buy
102,600
+92,600
+926% +$14.9M 0.07% 271
2017
Q4
$1.65M Sell
10,000
-168,350
-94% -$27.7M 0.01% 622
2017
Q3
$11.1M Buy
178,350
+53,350
+43% +$3.32M 0.05% 307
2017
Q2
$9.96M Sell
125,000
-270,300
-68% -$21.5M 0.06% 327
2017
Q1
$28.1M Buy
395,300
+330,800
+513% +$23.5M 0.16% 162
2016
Q4
$3.29M Sell
64,500
-102,100
-61% -$5.21M 0.02% 462
2016
Q3
$7.67M Sell
166,600
-1,100
-0.7% -$50.7K 0.05% 308
2016
Q2
$5.05M Buy
+167,700
New +$5.05M 0.03% 391